Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 74
- +4 vs. Q4 2021
- Portfolio value
- $1.95B
- −$567.6M (−22.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $164.4M | 8.5% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,075,905 | $117.2M | 6.0% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 3,192,058 | $102.7M | 5.3% | −1,152,958−26.5% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $94.3M | 4.8% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,484,264 | $88.9M | 4.6% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,669,132 | $79.9M | 4.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $77.3M | 4.0% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,498,636 | $72.8M | 3.7% | +660,400+23.3% | Added | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $69.0M | 3.5% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,303,700 | $66.2M | 3.4% | +1,303,700 | New | History |
| RXDXPrometheus Biosciences, Inc. | COM | 1,714,000 | $64.7M | 3.3% | +1,714,000 | New | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 700,000 | $62.9M | 3.2% | −1,500,000−68.2% | Reduced | – |
| TNGXTango Therapeutics, Inc. | COM | 6,871,642 | $52.1M | 2.7% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $50.2M | 2.6% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $45.2M | 2.3% | 00.0% | Unchanged | History |
| RETAReata Pharmaceuticals Inc | CL A | 1,239,000 | $40.6M | 2.1% | +1,239,000 | New | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $36.2M | 1.9% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 507,374 | $32.4M | 1.7% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,935,133 | $32.2M | 1.7% | +835,133+75.9% | Added | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $32.2M | 1.7% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,263,930 | $30.6M | 1.6% | +1,078,930+583.2% | Added | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,200,000 | $28.3M | 1.5% | +2,200,000 | New | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $24.6M | 1.3% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $23.3M | 1.2% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,341,009 | $22.8M | 1.2% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $22.0M | 1.1% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $22.0M | 1.1% | 00.0% | Unchanged | – |
| GOSSGossamer Bio, Inc. | COM | 2,462,358 | $21.4M | 1.1% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 1,847,559 | $20.8M | 1.1% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $20.7M | 1.1% | 00.0% | Unchanged | – |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $19.9M | 1.0% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $19.4M | 1.0% | 00.0% | Unchanged | History |
| GHRSGH Research PLC | ORDINARY SHARES | 1,013,399 | $18.5M | 1.0% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $18.3M | 0.9% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $17.2M | 0.9% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $16.8M | 0.9% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 200,000 | $14.5M | 0.7% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,238,861 | $14.4M | 0.7% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $11.8M | 0.6% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $11.8M | 0.6% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $11.3M | 0.6% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $11.2M | 0.6% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $11.0M | 0.6% | 00.0% | Unchanged | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 400,000 | $10.7M | 0.6% | +400,000 | New | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 892,057 | $10.3M | 0.5% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $7.84M | 0.4% | +459,836 | New | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $7.63M | 0.4% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $6.98M | 0.4% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 5,336,031 | $6.40M | 0.3% | +2,158,329+67.9% | Added | History |
| Rain Oncology Inc.75082Q105 | COM | 1,175,000 | $5.96M | 0.3% | 00.0% | Unchanged | – |
| ORICOric Pharmaceuticals, Inc. | COM | 1,054,000 | $5.63M | 0.3% | +854,000+427.0% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $5.58M | 0.3% | 00.0% | Unchanged | History |
| ODTOdonate Therapeutics, Inc. | COM | 4,207,086 | $5.55M | 0.3% | 00.0% | Unchanged | History |
| CDAKCodiak BioSciences, Inc. | COM | 850,065 | $5.33M | 0.3% | 00.0% | Unchanged | History |
| BMEABiomea Fusion, Inc. | COM | 1,188,405 | $5.30M | 0.3% | 00.0% | Unchanged | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $4.93M | 0.3% | 00.0% | Unchanged | – |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $4.88M | 0.3% | 00.0% | Unchanged | – |
| EPIXESSA Pharma Inc. | COM NEW | 724,500 | $4.49M | 0.2% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $4.13M | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $4.04M | 0.2% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $3.96M | 0.2% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $3.45M | 0.2% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 2,134,598 | $3.39M | 0.2% | 00.0% | Unchanged | History |
| ALGSAligos Therapeutics, Inc. | COM | 1,526,048 | $3.28M | 0.2% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 872,780 | $2.20M | 0.1% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $1.96M | 0.1% | 00.0% | Unchanged | – |
| IRONDisc Medicine, Inc. | COM | 1,300,000 | $1.81M | 0.1% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $1.75M | 0.1% | 00.0% | Unchanged | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 1,134,453 | $1.42M | 0.1% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $1.10M | 0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $1.07M | 0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $203.0K | <0.1% | 00.0% | Unchanged | – |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 56,950 | $123.0K | <0.1% | +56,950 | New | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $17.0K | <0.1% | +66,666 | New | – |
Sold out since Q4 2021 (4)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $4.88M | 0.2% | History |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $4.88M | 0.2% | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $3.96M | 0.2% | History |
| SRZNSurrozen, Inc. | COM | 200,000 | $1.29M | 0.1% | History |